True to its rich history of innovation, Penn State Heart and Vascular Institute at Penn State Health Milton S. Hershey Medical Center offers advanced therapies available only through clinical trials — treatments in the vanguard of care that can improve quality of life while laying the groundwork to help untold numbers of patients enjoy a brighter future.
Treatment of skull base tumors, including those affecting the pituitary gland, traditionally entailed opening the skull or making large incisions in the face and removing parts of the facial bones. These invasive procedures caused significant pain and scarring and required long hospital stays.
Penn State Health Milton S. Hershey Medical Center is one of eight academic medical centers nationwide taking part in a clinical trial of Cxbladder — a noninvasive test that could spare thousands of patients the pain and expense involved in evaluating a diagnosis of hematuria.
Patients with a noninvasive, low-grade form of bladder cancer often need multiple surgeries to treat recurrences, which are common. A new chemoablative gel currently under study at Penn State Health may eliminate the need for those procedures.
A team of experienced pediatricians and support staff in the Pediatric Complex Care program at Penn State Children’s Hospital collaborates to deliver advanced treatments to patients with multiple chronic illnesses, improving outcomes while helping families overcome socioeconomic and other barriers to care.
- 1 of 15
- next ›